Impacts of Social Inequality on Psychedelic Healing with Sean Viña, PhD

Impacts of Social Inequality on Psychedelic Healing with Sean Viña, PhD

Author: Lynn Marie Morski, MD, JD February 19, 2026 Duration: 39:04

In this episode, Dr. Sean M. Viña joins to discuss the ways that social inequality can impact psychedelic healing. Dr. Viña is a sociologist with a PhD from Indiana University whose research focuses on psychedelics and mental health, and social inequality.

In this conversation, Dr. Viña explains that while psychedelics are often framed as transformative treatments, their benefits appear unevenly distributed and frequently constrained by structural factors such as income inequality, education, stigma, caregiving burden, segregation, and social isolation. The discussion highlights how women—particularly single mothers—may experience diminished gains due to caregiving demands and stigmatization of mental illness, while Black and Latino populations show little measurable benefit once socioeconomic inequality is accounted for. Throughout, Dr. Viña emphasizes that outcomes are shaped less by the substances themselves than by the sociocultural environments people return to after treatment, underscoring the importance of community integration and structural supports alongside clinical care.

 

In this episode, you'll hear:

  • What inspired Dr. Viña to research social inequality and psychedelics
  • How caregiving burden, education, and stigma modulate women's mental health outcomes following psychedelic use
  • Why socioeconomic inequality appears to eliminate measurable benefits for many Black and Latino participants
  • The role of segregation, policing environments, and chronic stress in shaping treatment outcomes
  • Why American Indian populations respond better to psychedelic treatments in rural areas with greater access to nature and their culture
  • How having access to private versus public health insurance can impact psychedelic healing
  • Why focusing only on therapist–patient interactions may miss key determinants of success
  • Implications for designing more equitable psychedelic treatments and research

 

Quotes:

"Women who are highly educated actually seem to be getting about as much benefit [from psychedelic treatments] as men who are highly educated, but [lack of] education doesn't seem to negatively affect men the same way it affects women. Again, that's the pattern we see in all kinds of other health resources." [9:36]

"One of the studies that we did showed that if it wasn't for education and income differences, there would be a slight benefit [from psychedelics] for black participants in these surveys. But as soon as you accounted for education inequality and income inequality, it was wiped out." [21:40]

"I love the concept of the psychedelic renaissance, but when we start thinking about the statistics of who this is helping, this is a renaissance of less than 1% of people, right? This is a very small group of people who are getting benefits, just like many of the other resources that have come out in the past. … all these resources are probably valuable. They're all helpful. But there needs to be more than just the drug. There needs to be a bigger conversation about this society and the community that people are living in." [36:31]

 

Dr. Viña's academic articles:

"Medical Sociological and Epidemiological Psychedelics Paradigm", Drug Science Policy and Law, 2025

"A Community Centered Approach to Psychedelics", Discover Mental Health, 2025

"Unequal Healing: Gender, Psychedelics, and the Burden of Care", Women and Therapy, 2026

"Psychedelics and Mental Health Treatment Seeking Among Asians and Hawaiians", Psychoactives, 2025

"American Indian areas and psychedelics: A test of the minorities' diminished psychedelic returns", Journal of Rural Mental Health, 2025

"Religious Social Integration, Psychedelics, and Psychological Distress", Journal of Psychoactive Drugs, 2024

"Stigma, Psychedelic Use, and the Risk of Reduced Formal Mental Health Care", Stigma and Health, 2024

With Amanda L. Stephens: "Minorities' Diminished Psychedelic Returns." Drug Science, Policy and Law, 2023

Links:

Dr. Viña on LinkedIn

Dr. Viña on Researchgate

Previous episode: Psychedelics and Religion with Hunt Priest, MDiv

Psychedelic Medicine Association

Porangui


Exploring the frontier of mind and medicine, the Psychedelic Medicine Podcast with Dr. Lynn Marie Morski delves into the complex world of psychedelic substances and their potential to heal. Hosted by Lynn Marie Morski, a physician and attorney, this podcast navigates the intricate intersection of cutting-edge science, clinical practice, and evolving policy. Each episode brings a grounded, expert perspective to conversations about psilocybin, MDMA, ketamine, LSD, ayahuasca, ibogaine, and other compounds, moving beyond hype to examine the real-world implications of this therapeutic renaissance. Listeners will hear detailed discussions on the latest peer-reviewed research, practical insights from medical professionals integrating these approaches, and thoughtful analysis of the legal landscape shaping access. The dialogue is rooted in a commitment to safety, ethics, and evidence, offering a clear-eyed look at both the profound promise and the challenges inherent in psychedelic medicine. Whether you're a healthcare provider, a patient, a researcher, or simply intellectually curious, this podcast provides an essential, nuanced resource for understanding how these ancient and modern substances are reshaping perspectives on mental health, consciousness, and treatment. It’s a space for serious inquiry, where complex questions about healing, neuroscience, and society are met with informed, accessible conversation.
Author: Language: English Episodes: 100

Psychedelic Medicine Podcast with Dr. Lynn Marie Morski
Podcast Episodes
Microdosing Psilocybin: Truth vs Hype with Rotem Petranker, PhD [not-audio_url] [/not-audio_url]

Duration: 47:32
In this episode Rotem Petranker, PhD joins to discuss the current state of research on microdosing psilocybin. Dr. Petranker is the co-founder of the Psychedelic Studies Research Program at the University of Toronto and…
Encore Episode: Exploring Endogenous DMT with Rick Strassman, MD [not-audio_url] [/not-audio_url]

Duration: 52:41
In this episode of the Psychedelic Medicine Podcast, Rick Strassman, MD joins to discuss the topic of endogenous DMT. Dr. Strassman is adjunct associate professor of psychiatry at the University of New Mexico in Albuquer…
Psychedelics for Stroke Healing with Steven Zeiler, MD, PhD [not-audio_url] [/not-audio_url]

Duration: 32:57
In this episode Steven Zeiler, MD, PhD joins to discuss the promise of psychedelics for stroke healing. Dr. Zeiler is an associate professor and physician at Johns Hopkins School of Medicine specializing in cerebrovascul…
Long-Term Psychedelic Integration with J. Ashley T. Booth, LCSW, MS [not-audio_url] [/not-audio_url]

Duration: 34:40
In this episode J. Ashley T. Booth, LCSW, MS joins to discuss the importance of long-term psychedelic integration. Ashley is a Los Angeles-based psychedelic therapist, IFS practitioner, and author of Quieting the Storm W…
Is Psilocybin Safe for Me? with Seth Mehr, MD [not-audio_url] [/not-audio_url]

Duration: 52:41
In this episode, Seth Mehr, MD joins to share his expertise on safety planning prior to a patient undergoing psilocybin therapy. After a 20 year career as an Emergency Medicine physician, Seth founded Cascade Psychedelic…